This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Means

Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are two names for the same type of cancer that affects lymphocytes, a kind of white blood cell that helps your body fight infections. This cancer grows slowly, which is why it’s often called indolent. The main difference between CLL and SLL is where the cancer cells are mostly found. In CLL, cancer cells are mainly in the blood and bone marrow, the soft tissue inside bones where blood cells are made. In SLL, cancer cells are mostly in the lymph nodes, small bean-shaped structures that help filter harmful substances and fight infection. Both CLL and SLL are types of non-Hodgkin lymphoma, a broad group of cancers that start in the lymph system.

Why This Concept Matters in Cancer Care

Knowing whether the cancer is mostly in the blood and bone marrow (CLL) or mainly in the lymph nodes (SLL) helps doctors decide how to monitor and treat the disease. Because CLL/SLL usually grows slowly, many people may not have symptoms when first diagnosed. Sometimes it’s found during routine blood tests before any signs appear. When symptoms do occur, they might include swollen lymph nodes, feeling tired, or infections due to a weakened immune system. Understanding this helps patients and caregivers know what to expect and when treatment might be needed.

What Patients Might See or Hear About CLL/SLL

If you or a loved one is diagnosed with CLL or SLL, you might hear these terms during discussions about diagnosis, test results, or treatment options. You may see them in medical reports, treatment plans, or information about clinical trials. Because CLL and SLL are the same disease but show up in different places, hearing both terms can be confusing. It’s okay to ask your healthcare team to explain what the diagnosis means for your specific situation, including where the cancer cells are mostly located and what symptoms to watch for.

What CLL/SLL Does Not Automatically Mean

Having CLL or SLL does not automatically mean the cancer is aggressive or that you will have symptoms right away. Many people live with this condition for years without needing treatment. Doctors use this diagnosis along with other tests to decide when treatment is needed and what kind might be best. The disease can behave differently from person to person, so hearing the term alone doesn’t tell the whole story.

How Doctors Use the Concept During Care

Doctors use the terms CLL and SLL to describe where the cancer cells are most concentrated, but the underlying disease process is the same. This helps guide monitoring and treatment decisions. Tests such as blood tests, bone marrow biopsies, and imaging help determine the extent of the disease. Because CLL/SLL is a type of B-cell lymphoma, it is part of a larger group of lymphomas that affect B lymphocytes. Treatment plans and follow-up depend on the disease’s behavior and symptoms.

Common Questions to Ask Your Care Team

It can help to ask questions like: Where is the cancer mostly located? What symptoms should I watch for? How will you monitor the disease? When might treatment be needed? What treatment options are available if the disease changes? These questions can help you understand your condition better and feel more confident in managing your care.

Understanding This Information and Next Steps

This information is meant to help you learn about CLL/SLL but cannot replace personalized advice from your healthcare team. If you or a loved one has been told about CLL or SLL, the next step is to talk openly with your care team about what this means for your health, what tests you might need, and how your disease will be monitored or treated. Learning about this condition can help you feel more confident in managing your care and asking questions that matter to you.

Sources

Public source information used for this glossary entry includes: